The 20 Best Pleuropulmonary Blastoma Doctors Near Me in Alexandria, VA

Ivan Aksentijevich is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Aksentijevich is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Pleuropulmonary Blastoma, and Multiple Myeloma.

Jacob Ninan is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Ninan is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Pulmonary Embolism, Saddle Pulmonary Embolism, and Colorectal Cancer.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Levy is board certified in American Board Of Internal Medicine.

Stephen R. Broderick, M.D., MPHS, is an assistant professor of surgery at Johns Hopkins University School of Medicine and a thoracic surgeon, part of a multidisciplinary team treating lung cancer patients in the Johns Hopkins Kimmel Cancer Center. Listen to Dr. Broderick's Cancer Matters podcast episode to learn more about his work. Dr. Broderick's primary clinical focus is at Sibley Memorial Hospital, in Washington, D.C. He also practices at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore, Maryland. Dr. Broderick has a clinical expertise in surgical treatment of lung cancer, esophageal cancer and other thoracic malignancies, as well as benign thoracic conditions. This includes achalasia, bronchoscopy, chest wall reconstruction and tumors, lung nodules and paraesophageal hernias. He has a clinical interest in minimally invasive surgery for lung cancer and the coordinated delivery of multidisciplinary care for thoracic oncology patients. Before joining Johns Hopkins, Dr. Broderick was a thoracic surgeon at St Luke’s Hospital, where he served as the medical director of the cardiothoracic intensive care unit and a member of the oncology steering committee. He also served as an instructor of surgery at Washington University School of Medicine. Dr. Broderick received his medical degree from Georgetown University School of Medicine in 2003 and he completed his internship and residency training in general surgery at New York-Presbyterian Hospital. He studied the molecular biology of lung cancer as a research fellow at Memorial Sloan Kettering Cancer Center, where he received the Chairman's Award for outstanding contributions to the basic science research fellowship. Dr. Broderick also completed a fellowship in thoracic surgery at Washington University School of Medicine in 2012 and earned a Masters in Population Health Science from Washington University School of Medicine in 2014. Dr. Broderick is a member of the American College of Chest Physicians, The Society of Thoracic Surgeons and the American Society of Clinical Oncology. Dr. Broderick’s research interests are focused on improving outcomes for lung cancer patients. He is particularly interested in studying how various treatments for early-stage lung cancer impact patients’ quality of life. Dr. Broderick has contributed to numerous publications and is a reviewer for the Journal of Cardiovascular and Thoracic Surgery, as well as Annals of Thoracic Surgery. Dr. Broderick is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Tubal Ligation, and Lung Transplant. Dr. Broderick is board certified in American Board Of Thoracic Surgery and American Board Of Surgery.

Keith Mortman is a Thoracic Surgeon practicing medicine in Washington, Washington, D.c.. Dr. Mortman is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Lung Nodules, Thymectomy, and Endoscopy. Dr. Mortman is board certified in American Board Of Thoracic Surgery.

Nitika Paudel is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Paudel is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).

Dr. Nicole Laslett is a specialty care physician board certified in internal medicine, medical oncology, and hematology. She joined Inova in 2025 and has been practicing since 2015. Prior to joining Inova, Dr. Laslett served as a physician at Christiana Care Oncology Hematology at the Helen F. Graham Cancer Center and Research Institute in Newark, DE, where she was also a Core Faculty member. Additionally, she held academic appointments as a Clinical Assistant Professor of Medicine at both Thomas Jefferson University and the Philadelphia College of Osteopathic Medicine. Dr. Laslett is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Paget Disease of the Breast, and Breast Cancer.

Dr. Gregory D. Trachiotis is a thoracic surgeon at Sibley Memorial Hospital, as well as a professor of surgery and chief of cardiothoracic surgery at George Washington University Medical Center. He is also the chief of cardiac surgery at the Veterans Affairs Medical Center. Dr. Trachiotis practices out of MFA CardioThoracic Surgery in Washington, D.C. He is affiliated with Sibley Memorial Hospital, Washington D.C. Veterans Affairs Medical Center and George Washington University Hospital. His clinical interests include end-stage heart and lung disease, video-assisted thoracic surgery, lung cancer, coronary artery disease, aortic valvular disease, mitral valve disorders, off-bypass coronary revascularization, mini-pump technology, surgery for heart failure, mechanical assist devices, esophageal cancer, motility disorders and transcatheter valve replacement. Dr. Trachiotis earned his medical degree from George Washington University School of Medicine, where he went on to complete residencies in cardiovascular and thoracic surgery. He earned the positions of chief resident and instructor of surgery at George Washington University, as well as chief resident of vascular surgery at the Veterans Affairs Medical Center. Dr. Trachiotis also completed a fellowship in heart and lung transplant surgery at Emory University and affiliated hospitals in Atlanta, Ga. Dr. Trachiotis is a fellow of the American College of Surgeons and is a member of various professional organizations, including the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, the International Society of Heart and Lung Transplantation, the American Heart Association Council on Cardiothoracic and Vascular Surgery and the American College of Chest Physicians. Dr. Trachiotis has earned numerous awards, including being named a Top Doctor and Top Cardiothoracic Surgeon by Washingtonian Magazine and a Regional Top Doctor by Castle Connolly. He has also earned the Outstanding Chief of Surgery Resident Award from George Washington University; the Chest Foundation’s American College of Chest Physicians Young Investigator Award; and the Alley-Sheridan Scholar Harvard Health Policy and Secretary of Veterans Health Affairs Hand and Heart Award. Dr. Trachiotis has contributed to numerous clinical trials, publications and presentations. He runs a cardiothoracic surgery clinical research program for surgical residents from Georgetown University and George Washington University. Dr. Trachiotis' research interests include outcome analysis utilizing cardiac imaging for identifying prognostic risk factors in cardiac surgery; AIDS-related thoracic and cardiac disease; cardiovascular disease in sleep apnea and right heart dysfunction; donor heart and lung preservation; imaging and revascularization for LV dysfunction and valvular heart surgery; and cancer and tumor markers in esophageal and lung cancer. Dr. Trachiotis is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery. Dr. Trachiotis is board certified in American Board Of Thoracic Surgery.

Robert Christie is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).

John Feigert is a Hematologist and an Oncologist practicing medicine in Arlington, Virginia. Dr. Feigert is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 65 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Familial Colorectal Cancer, Multiple Myeloma, and Chronic Lymphocytic Leukemia (CLL).

Khaled M. El-Shami, M.B.Ch.B., Ph.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology in the Division of Hematologic Malignancies at Johns Hopkins University School of Medicine. Listen to Dr. El-Shami's Cancer Matters podcast episode to learn more about his work. Dr. El-Shami's clinical interests are in hematologic malignancies, including leukemias, lymphomas and myelomas.. Dr. El-Shami graduated from Alexandria University Faculty of Medicine in Alexandria, Egypt, where he did a residency in the Department of Neurosurgery. He was a Chevening Scholar as a M.S. student in molecular genetics at the University of Sussex in the United Kingdom, as well as a Sam Cohen Windhoek Scholar as a Ph.D. student in cancer immunology at the Weizmann Institute in Israel. Dr. El-Shami also completed a residency in internal medicine at George Washington University School of Medicine, a fellowship in tumor immunology and biology at the National Cancer Institute, and a fellowship in medical oncology at Johns Hopkins University School of Medicine. Dr. El-Shami previously served as faculty at Georgetown University and George Washington University. Dr. El-Shami has been named a Top Doctor by Washingtonian Magazine for several years. Dr. El-Shami is a member of the American Association for Advancement of Science, the American Association of Cancer Research, the American Association of Immunologists, the American Society for Gene Therapy and the American Society of Clinical Oncology. Dr. El-Shami's research focus is on hematologic malignancies, including acute and chronic leukemias, myelodysplastic syndromes, myeloprolifetive neplasms and lymphomas. He has received the National Institutes of Health Clinical Research Scholars Award, an American Medical Association Seed Grant and an American Society of Clinical Oncology Merit Award. Dr. El is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer. Dr. Halthore is board certified in American Board Of Radiology.

Victoria J. Croog, M.D., Department of Radiation Oncology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital, as well as a clinical associate in the Department of Radiation Oncology at The Johns Hopkins Hospital. Dr. Croog has expertise in breast cancer, gastrointestinal cancer, gynecologic cancer, brain cancer and tumors of the central nervous system. Dr. Croog earned her medical degree from Harvard Medical School. She completed an internship and a residency in radiation oncology at Memorial Sloan-Kettering Cancer Center. Dr. Croog is involved with several committees at Sibley Memorial Hospital, including the Medical Executive Committee, the IRB/Research Review Committee, the Cancer Committee and the Radiation Safety Committee. She is also a member of the American Society of Clinical Oncology and the American Society of Radiation Oncology. Dr. Croog has been repeatedly named a Top Doctor by Washingtonian Magazine. Dr. Croog has been published in numerous peer-reviewed journals and has presented research at various conferences, such as the American Society of Clinical Oncology’s annual meeting. Make A Gift LinkedIn https://www.linkedin.com/in/victoria-croog-88a31759. Dr. Croog is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Breast Cancer, and Familial Pancreatic Cancer. Dr. Croog is board certified in American Board Of Radiology.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy. Dr. Kressel is board certified in American Board Of Internal Medicine.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, and Prostate Cancer. Dr. Kumar is board certified in American Board Of Radiology.

Mark Goldstein is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Goldstein is rated as a Distinguished provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma. Dr. Goldstein is board certified in American Board Of Internal Medicine.

Arjun Sood is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Sood is rated as an Advanced provider by MediFind in the treatment of Pleuropulmonary Blastoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Pleuropulmonary Blastoma.

Alina Huang is a Hematologist and an Oncologist practicing medicine in Alexandria, Virginia. Dr. Huang is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Pulmonary Embolism.

Dr. Yoomi Lee is a specialty care physician board certified in medical oncology, hematology and internal medicine. She joined Inova Medical Group with more than ten years of clinical experience. She has a special interest in the management of gastrointestinal malignancies. Most recently, Dr. Lee served as a medical oncologist at Maryland Oncology Hematology and prior to that as an attending physician at Columbia University Medical Center. Dr. Lee has had a lifelong interest in science and became interested in oncology during her undergraduate education at Yale University. Her goal is to help her patients access state-of-the-art multidisciplinary cancer care in a supportive environment. A native of Seoul, South Korea, and Sydney, Australia, Dr. Lee currently resides in Washington, DC, with her husband and son. In her spare time, she likes to read books, travel and cook. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, and Myelodysplastic Syndrome (MDS).

Dr. Melissa Yacur is a specialty care physician board certified in medical oncology and hematology. She joined Inova in 2022 and has been practicing since 2015.Prior to joining Inova, Dr. Yacur was a hematology and oncology fellow at the University of Virginia in Charlottesville, VA. Dr. Yacur is rated as an Experienced provider by MediFind in the treatment of Pleuropulmonary Blastoma. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Breast Cancer in Men, and Breast Cancer.